drugset / Trial / NCT06562582

STunning in Acute Myocardial Infarction - BAS

NCT06562582

Phase 4 Recruiting 120 enrolled Vastra Gotaland Region
RandomizedFactorialOpen-labelTreatment

Summary

The objective of this trial is to examine the effect of immediate versus late administration of beta blockers, angiotensin converting enzyme inhibitors (ACEI), and sodium/glucose cotransporter 2 (SGLT2) inhibitors on echocardiographic parameters and biomarkers in subjects with ST-elevation myocardial infarction (STEMI)

Timeline

Start
2025-01-06
Primary completion
2027-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisoprolol Other / unclassified Oral
Comparator Dapagliflozin Small molecule Oral
Comparator Ramipril Small molecule Oral

Indications